This year the National Immunisation Programme will use a more comprehensive, quadrivalent influenza vaccine that protects against four types of virus. The Immunisation Programme includes an influenza vaccine administered as a nasal spray vaccine (children aged 2-6) and as an injectable vaccine, which both provide more comprehensive protection than last year’s vaccine.

The National Institute for Health and Welfare (THL) has conducted a study of HPV vaccine administered to girls in the years 2013–2015. The study investigated whether the vaccine increases the risk of autoimmune disorders. There were approximately 241,000 subjects in all. Approximately half of them, or 56 percent, received the vaccine. HPV vaccine prevents HPV viral infection and the precursors of cervical cancer that it causes.

The national vaccination register of Finland shows that influenza vaccination coverage of children below three years of age improved by three percentage points this season. Influenza vaccination coverage for people 65 years of age and older also increased slightly and is currently at 48 per cent.

The national vaccination register’s vaccination coverage report shows that there has been a good vaccination coverage rate throughout Finland for children born in 2015. There are differences depending on the type of vaccine and the region, however.

Free influenza vaccinations began across Finland in November. Getting an influenza vaccination is particularly important for people over 65 years of age, pregnant women and those suffering from chronic illnesses. 

The rotavirus vaccine was added to the National Immunisation Programme in 2009. Since that time, the instances of hospital treatment caused by the rotavirus have decreased by as much as 93% among children under five years of age.

There is a worrying measles epidemic in Europe, with hundreds of new cases reported during the summer. Of the five cases reported in Finland, the most recent one was an adult who had not been vaccinated against measles.

Chickenpox vaccinations will begin in September. In the first round, the vaccine will be administered to children from 1.5-year-olds to fifth-graders who have never had chickenpox. Children will be vaccinated in conjunction with their routine check-ups. For school pupils, this will take place in the school nurse’s office, while younger children will receive their vaccinations at child health clinics.

The MMR vaccine, which provides immunity against mumps, rubella and measles was added to the National Immunisation Programme in 1982. People who were born in the late 1960s and early 1970s, who are now entering their fifties, are likely to have never received this vaccination.